The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease
Open accessAbstract
Parkinson disease (PD) is a neurodegenerative disorder characterized by a loss of the nigrostriatal dopaminergic neurons accompanied by a deficit in mitochondrial respiration. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that causes dopaminergic neurodegeneration and a mitochondrial deficit reminiscent of PD. Here we show that the infusion of the ketone body D-β-hydroxybutyrate (DβHB) in mice confers partial protection against dopaminergic neurodegeneration and motor deficits induced by MPTP. These effects appear to be mediated by a complex II–dependent mechanism that leads to improved mitochondrial respiration and ATP production. Because of the safety record of ketone bodies in the treatment of epilepsy and their ability to penetrate the blood-brain barrier, DβHB may be a novel neuroprotective therapy for PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“also protects dopaminergic neurons in an animal model of PD”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Tieu et al., 2003
In the citing paper
“Carnitine and β-hydroxybutyrate has shown to protect against MPTP toxicity189-191.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
Brain Metabolism during Fasting*
Owen, O. E., Morgan, A. P., Kemp, H. G., Sullivan, J. M., Herrera, M. G., & Cahill, G. F. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105650 · Cited by 1,662
Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,273
Javitch, J. A., D’Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,264
Generation of reactive oxygen species by the mitochondrial electron transport chain
Liu, Y., Fiskum, G., & Schubert, D. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00744.x · Cited by 1,260
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046
Self-citationHeikkila, R. E., Manzino, L., Cabbat, F. S., & Duvoisin, R. C. (1984) · Nature · doi:10.1038/311467a0 · Cited by 1,010
Anson, R. M., Guo, Z., de Cabo, R., Iyun, T., Rios, M., Hagepanos, A., Ingram, D. K., Lane, M. A., & Mattson, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1035720100 · Cited by 732
Flagged first, then by citations
Research works printed but not linked: 2
- Giovanni, 1991, J. Pharmacol. Exp. Ther., 257, 691
- Plecko, 2002, Pediatr. Res., 52, 301
Cited by
Sorted by citations
Items 301–400 of 497
Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond
Brown, E. G., & Goldman, S. M. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00942-2 · Cited by 24
Weerasekera, A., Sima, D. M., Dresselaers, T., Huffel, S. V., Damme, P. V., & Himmelreich, U. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.09.011 · Cited by 20
Kraeuter, A.-K., Guest, P. C., & Sarnyai, Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-25650-0_5 · Cited by 24
Montiel, T., Gómora‐García, J. C., Gerónimo‐Olvera, C., Heras‐Romero, Y., Bernal‐Vicente, B. N., Pérez-Martı́nez, X., Tovar‐y‐Romo, L. B., & Massieu, L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15852 · Cited by 22
Role of Mitochondrial Dysfunction in Parkinson???s Disease
Ramsey, C. P., & Giasson, B. I. (2007) · Drugs & Aging · doi:10.2165/00002512-200724020-00002 · Cited by 22
Role of HCA2 in Regulating Intestinal Homeostasis and Suppressing Colon Carcinogenesis
Li, Z., MCCAFFERTY, K. J., & Judd, R. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.606384 · Cited by 21
ß-Hydroxybutyrate Improves Mitochondrial Function After Transient Ischemia in the Mouse
Lehto, A., Koch, K. A., Barnstorf-Brandes, J., Viel, C., Fuchs, M., & Klein, J. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03637-6 · Cited by 21
Mallet, D., Goutaudier, R., Barbier, E., Carnicella, S., Colca, J. R., Fauvelle, F., & Boulet, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02962-9 · Cited by 21
Cuerda‐Ballester, M., Proaño, B., Alarcón-Jiménez, J., de Bernardo, N., Villarón-Casales, C., Lajara-Romance, J. M., & Ortí, J. E. D. L. R. (2023) · Food & Function · doi:10.1039/d2fo02207a · Cited by 21
The proteomic effects of ketone bodies: implications for proteostasis and brain proteinopathies
García‐Velázquez, L., & Massieu, L. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1214092 · Cited by 21
Mitochondrial dysfunction in the striatum of aged chronic mouse model of Parkinson’s disease
Patki, G. (2009) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.003.2009 · Cited by 20
Marcogliese, P. C., Abuaish, S., Kabbach, G., Abdel-Messih, E., Seang, S., Li, G., Slack, R. S., Haque, M. E., Venderova, K., & Park, D. S. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx030 · Cited by 20
D-β-Hydroxybutyrate Prevents MPP+-Induced Neurotoxicity in PC12 Cells
Cheng, B., Yang, X., Chen, C., Cheng, D., Xu, X., & Zhang, X. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0078-6 · Cited by 20
Hein, Z. M., Arbain, M. F. F., Kumar, S., Mehat, M. Z., Hamid, H. A., Ramli, M. D. C., & Nassir, C. M. N. C. M. (2025) · Nutrients · doi:10.3390/nu17142266 · Cited by 25
Effects of ketogenic diet on oxidative stress and cancer: A literature review
Alhamzah, S. A., Gatar, O. M., & Alruwaili, N. W. (2023) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2023.100093 · Cited by 19
ALS Untangled No. 20: The Deanna Protocol
The ALSUntangled Group (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.788405 · Cited by 19
Deepika, N. P., Kondengadan, S. M., Sweilam, S. H., Rahman, M. H., Muhasina, K. M., Ghosh, P., Pulukuri, D. B., Palati, D. J., Maiz, F., & Duraiswamy, B. (2022) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2022.2122296 · Cited by 21
Missiego-Beltrán, J., Olalla-Álvarez, E. M., González-Brugera, A., & Beltrán-Velasco, A. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168998 · Cited by 19
Sechi, G., & Sechi, M. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011198 · Cited by 19
Chung, J. Y., Lee, J. W., Ryu, C. H., Min, H. K., Yoon, Y. J., Lim, M. J., & Park, C. H. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23577 · Cited by 18
Suzuki, W. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.022 · Cited by 17
Ehtiati, S., Hatami, B., Khatami, S. H., Tajernarenj, K., Abdi, S., Sirati‐Sabet, M., Hashemi, S. A. H. G., Ahmadzade, R., Hamed, N., Goudarzi, M., et al. (2025) · Journal of Cellular Biochemistry · doi:10.1002/jcb.70050 · Cited by 17
Koskimäki, J. J., Pohjanen, J., Kvist, J., Fester, T., Härtig, C., Podolich, O. V., Fluch, S., Edesi, J., Häggman, H., & Pirttilä, A. M. (2021) · Tree Physiology · doi:10.1093/treephys/tpab102 · Cited by 17
The role of lymphatic endothelial cell metabolism in lymphangiogenesis and disease
Simeroth, S., & Yu, P. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1392816 · Cited by 15
Bioplastic hydroxyl radical trapping
Messens, J. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2058 · Cited by 17
Hanhan, L., Perumal, N., Manicam, C., Mercieca, K., & Prokosch, V. (2020) · Pharmaceuticals · doi:10.3390/ph13090213 · Cited by 17
Ketogenic therapy towards precision medicine for brain diseases
Liu, Y., Fan, L., Yang, H., Wang, D., Liu, R., Shan, T., & Xia, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1266690 · Cited by 16
Grammatikopoulou, M. G., Tousinas, G., Balodimou, C., Anastasilakis, D. A., Gkiouras, K., Dardiotis, E., Evangeliou, A., Bogdanos, D. P., & Goulis, D. G. (2022) · Maturitas · doi:10.1016/j.maturitas.2022.06.001 · Cited by 16
Ketogenic diet and behavior: insights from experimental studies
Grabowska, K., Grabowski, M., Przybyła, M., Pondel, N., Barski, J. J., Nowacka-Chmielewska, M. M., & Liśkiewicz, D. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1322509 · Cited by 16
Najac, C., Radoul, M., Page, L. M. L., Batsios, G., Subramani, E., Viswanath, P., Gillespie, A. M., & Ronen, S. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-39677-2 · Cited by 17
Degeratu, C. N., Mabilleau, G., Aguado, E., Mallet, R., Chappard, D., Cincu, C., & Stancu, I. (2019) · Morphologie · doi:10.1016/j.morpho.2019.02.003 · Cited by 18
Ketogenic Diet and Gut Microbiota: Exploring New Perspectives on Cognition and Mood
Jiang, Y., Chen, Y., Chen, Y., Gong, X., Chen, Z., & Zhang, X. (2025) · Foods · doi:10.3390/foods14071215 · Cited by 15
Idzikowska, K., Gątarek, P., Gajda, A., Safiński, P., Przysło, Ł., & Kałużna‐Czaplińska, J. (2025) · Nutrients · doi:10.3390/nu17182969 · Cited by 19
Faria‐Pereira, A., Temido‐Ferreira, M., & Morais, V. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.837448 · Cited by 18
Gao, L., Cao, M., Du, G., & Qin, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.911924 · Cited by 15
Wang, L., Yang, Z., Fan, F., Sun, S., Wu, X., Lü, H., & Lu, X. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00408 · Cited by 15
Intermittent Fasting in Mice Does Not Improve Hindlimb Motor Performance after Spinal Cord Injury
Streijger, F., Plunet, W. T., Plemel, J. R., Lam, C. K., Liu, J., & Tetzlaff, W. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1715 · Cited by 15
Neuroprotective Effects of Oral Administration of Triacetyluridine Against MPTP Neurotoxicity
Klivènyi, P., Gardian, G., Calingasan, N. Y., Yang, L., von Borstel, R. W., Saydoff, J. A., Browne, S. E., & Beal, M. F. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:6:2-3:087 · Cited by 15
Gambardella, I., Ascione, R., D’Agostino, D. P., Ari, C., Worku, B., Tranbaugh, R. F., Ivascu, N. S., Villena‐Vargas, J., & Girardi, L. N. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15341 · Cited by 14
Scafidi, S., Jernberg, J. N., Fiskum, G. M., & McKenna, M. C. (2022) · Metabolites · doi:10.3390/metabo12080710 · Cited by 13
The impact of ketogenic diet on the onset and progression of multiple sclerosis
Brockhoff, J. D., Bereswill, S., & Heimesaat, M. (2023) · European Journal of Microbiology & Immunology · doi:10.1556/1886.2023.00020 · Cited by 14
Metodieva, V., Smith, T., & Gunn‐Moore, F. J. (2022) · eNeuro · doi:10.1523/eneuro.0040-22.2022 · Cited by 15
Polyhydroxyalkanoates (PHA) – Applications in Wound Treatment and as Precursors for Oral Drugs
de Souza, L., & Shivakumar, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-3759-8_9 · Cited by 14
Western and ketogenic diets in neurological disorders: can you tell the difference?
Habashy, K. J., Ahmad, F. A., Ibeh, S., Mantash, S., Kobeissy, F., Issa, H., Habis, R., Tfaily, A., Nabha, S. M., Harati, H., et al. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuac008 · Cited by 12
The interplay between glucose and ketone bodies in neural stem cell metabolism
Molloy, J. W., & Barry, D. (2024) · Journal of Neuroscience Research · doi:10.1002/jnr.25342 · Cited by 11
Cognitive impairment caused by compromised hepatic ketogenesis is prevented by endurance exercise
Kelty, T. J., Kerr, N. R., Chou, C. H., Shryack, G. E., Taylor, C. L., Krause, A. A., Knutson, A. R., Bunten, J., Childs, T. E., Meers, G. M.-E., et al. (2025) · The Journal of Physiology · doi:10.1113/jp287573 · Cited by 10
Time-dependent modulation of rat serum paraoxonase 1 activity by fasting
Thomàs‐Moyà, E., Nadal-Casellas, A., Gianotti, M., Lladó, I., & Proenza, A. M. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0174-2 · Cited by 11
Su, J., Wang, H., Yang, Y., Wang, J., Li, H., Huang, D., Huang, L., Bai, X., Yu, M., Fei, J., et al. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.06.010 · Cited by 11
Sayadi, J. J., Sayadi, L. R., Satteson, E., & Chopan, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244244 · Cited by 11
Yáñez, L., Rodríguez, Y., Scott, F., Vergara‐Fernández, A., & Muñoz, R. (2022) · Bioresource Technology · doi:10.1016/j.biortech.2022.127141 · Cited by 11
Tailored recycling chemicals and fuels from poly‐3‐hydroxybutyrate: A review
Kang, S., Liang, J., Yuan, H., Lin, F., Deng, D., & Fu, J. (2022) · Biofuels Bioproducts and Biorefining · doi:10.1002/bbb.2371 · Cited by 11
Beta-Hydroxybutyrate: A Supplemental Molecule for Various Diseases
Shahtaghi, N. R., Soni, B., Bakrey, H., Bigdelitabar, S., & Jain, S. K. (2024) · Current Drug Targets · doi:10.2174/0113894501312168240821082224 · Cited by 10
Jawharji, M. T., Alshammari, G. M., Binobead, M. A., Albanyan, N. M., Al‐Harbi, L. N., & Yahya, M. A. (2024) · Nutrients · doi:10.3390/nu16183074 · Cited by 11
Fasting mitigates immediate hypersensitivity: a pivotal role of endogenous D-beta-hydroxybutyrate
Nakamura, S., Hisamura, R., Shimoda, S., Shibuya, I., & Tsubota, K. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-40 · Cited by 11
Mitochondrial Dynamics in Neurodegenerative Diseases
Pinnell, J. R., & Tieu, K. (2017) · Advances in neurotoxicology · doi:10.1016/bs.ant.2017.07.006 · Cited by 10
Self-citationSequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
Gordon, J., Lockard, G., Monsour, M., Alayli, A., Choudhary, H., & Borlongan, C. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710138 · Cited by 10
White, H. T., Venkatesh, K., & Venkatesh, B. (2017) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.1000188 · Cited by 10
HSIEH, C.-L., Lin, P.-Y., Akita, T., Mita, M., Ide, T., Lee, J., & Hamase, K. (2018) · Chromatography · doi:10.15583/jpchrom.2018.021 · Cited by 10
Ketogenic Diet Consumption Inhibited Mitochondrial One-Carbon Metabolism
Hsu, F.-Y., Liou, J.-Y., Tang, F., Sou, N., Peng, J.-H., & Chiang, E. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073650 · Cited by 10
Liu, C., Zheng, X., Liu, L., Hu, Y., Zhu, Q., Zhang, J., Wang, H., Gu, E., Yang, Z., & Xu, G. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.828278 · Cited by 10
Storoni, M., Robert, M. P. A., & Plant, G. T. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1368170 · Cited by 10
Polyhydroxyalkanoates: Production and Use
Fernández-Bunster, G. C. (2016) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120049915 · Cited by 11
Wang, Y., Zhang, J., Zhang, Y., & Yao, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1066785 · Cited by 9
D-β-hydroxybutyrate inhibits microglial activation in a cell activation model in vitro
Xu, X.-D., Zhang, Q., Tu, J., & Ren, Z. (2011) · 中国人民解放军军医大学学报:英文版 · doi:10.1016/s1000-1948(11)60042-7 · Cited by 8
Influence of Exogenous β-Hydroxybutyrate on Walking Economy and Rating of Perceived Exertion
James, S., & Greer, B. K. (2018) · Journal of Dietary Supplements · doi:10.1080/19390211.2018.1471562 · Cited by 10
Caldwell, K. A., Thies, J. L., & Caldwell, G. A. (2018) · Metabolites · doi:10.3390/metabo8040070 · Cited by 9
Bisong, S. A., Nku, C. O., Sanya, O. A., Ita, S. O., Fischer, V. A., & Abuo, F. E. (2020) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2020.03.008 · Cited by 10
Chapter 8 Effect of Caloric Restriction on Oxidative Markers
Škrha, J. (2009) · Advances in clinical chemistry · doi:10.1016/s0065-2423(09)47008-2 · Cited by 9
Nabakhteh, S., Lotfi, A., Afsartaha, A., Khodadadi, E. S., Abdolghaderi, S., Mohammadpour, M., Shokri, Y., Kiani, P., Ehtiati, S., Khakshournia, S., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04830-8 · Cited by 8
Mitochondrial drug delivery systems
Hubbard, W. B., Vekaria, H. J., & Sullivan, P. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00017-6 · Cited by 8
Nitrogen-doped cobalt nanocatalysts for carbonylation of propylene oxide
Zeng, B., Chen, L., Zhu, G., Yang, B., Xia, C., & He, L. (2020) · Molecular Catalysis · doi:10.1016/j.mcat.2020.111109 · Cited by 8
Mitochondria and Parkinson's Disease
Simon, D. K., Chu, C. T., & Swerdlow, R. H. (2011) · Parkinson s Disease · doi:10.4061/2011/261791 · Cited by 8
Mitochondrial Damage in Traumatic CNS Injury
Hubbard, W. B., Davis, L. M., & Sullivan, P. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-77495-4_4 · Cited by 8
Bhubalan, K., Lee, W., & Sudesh, K. (2011) · doi:10.1002/9781118015810.ch8 · Cited by 8
Decreased β‐hydroxybutyrate and ketogenic amino acid levels in depressed human adults
Sato, S., Yu, Z., Sakai, M., Motoike, I. N., Saigusa, D., Hirayama, R., Kikuchi, Y., Abe, T., Kinoshita, K., Koshiba, S., et al. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15931 · Cited by 9
Carbajal, C., Rodriguez, M., Owens, F., Stone, N., Veeragoni, D., Fan, R. Z., Tieu, K., & El‐Hage, N. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030365 · Cited by 7
Self-citationLi, Y., Zhang, W., Zhang, Q., Li, Y., Xin, C., Tu, R., & Yan, H. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110283 · Cited by 12
Dapagliflozin for the treatment of type 1 diabetes mellitus
Pafili, K., Maltezos, E. S., & Παπάνας, Ν. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1339788 · Cited by 7
Dutta, A., Phukan, B. C., Roy, R., Mazumder, M. K., Paul, R. K., Choudhury, A., Kumar, D., Bhattacharya, P., Nath, J., Kumar, S., et al. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01001-9 · Cited by 7
Oxidative Stress in Military Missions—Impact and Management Strategies: A Narrative Analysis
Rădulescu, D., Mihai, F.-D., Trasca, M. E.-T., Căluianu, E. I., Calafeteanu, C. D. M., Radulescu, P.-M., Mercuţ, R., Ciupeanu-Călugăru, E. D., Marinescu, G.-A., Siloşi, C. A., et al. (2024) · Life · doi:10.3390/life14050567 · Cited by 7
Characteristics of ketogenic diet and its therapeutic properties in central nervous system disorders
Liśkiewicz, A., Jędrzejowska–Szypułka, H., & Lewin‐Kowalik, J. (2012) · Annales Academiae Medicae Silesiensis · Cited by 7
The therapeutic potential of ketone bodies in Parkinson’s disease
Thickbroom, G. W. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1881483 · Cited by 7
The Mitochondrial Connection in Parkinson's DiseasePreprint
Schon, E. A., Matheoud, D., & Przedborski, S. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041891 · Cited by 7
Self-citationWoytash, J., Lefebvre, A. E. Y. T., Zhang, Z., Xu, B., Harchenko, S. A., Le, H. T., McColloch, A. R., Shi, X., Digman, M. A., & Razorenova, O. V. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03163-6 · Cited by 6
Pancreas meets brain: β-hydroxybutyrate as a novel “β-cellular” metabolism therapy
Lopa, C., Pietrangelo, D., Santulli, G., Gambardella, J., Rubattu, S., Stefan–Lifshitz, M., Garcia, C. N., Jankauskas, S. S., & Lombardi, A. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156419 · Cited by 8
The ketogenic diet in Parkinson’s disease: a potential therapeutic strategy
Pokora, B., Pokora, K., Binienda, A., & Fichna, J. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00799-2 · Cited by 9
The ALSUntangled Group (2012) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2012.671629 · Cited by 6
Gambardella, I., Worku, B., Lau, C., Tranbaugh, R. F., Tabaie, S., Ivascu, N. S., & Girardi, L. N. (2022) · Annals of Surgery · doi:10.1097/sla.0000000000005572 · Cited by 6
Ketone ester–enriched diet ameliorates motor and dopamine release deficits in MitoPark mice
Mahajan, V. R., Nadel, J. A., King, M. T., Pawlosky, R. J., Davis, M. I., Veech, R. L., Lovinger, D. M., & Salinas, A. G. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16601 · Cited by 7
Relationship Between DNA Damage and Energy Metabolism: Evidence from DNA Repair Deficiency Syndromes
Vose, S. C., & Mitchell, J. R. (2011) · InTech eBooks · doi:10.5772/25053 · Cited by 6
Zhang, J., & Darley-Usmar, V. M. (2011) · Springer eBooks · doi:10.1007/978-0-85729-701-3_6 · Cited by 7
Ketogenic dietary therapy for epilepsy and other disorders: current perspectives
Neal, E. G. (2014) · Nutrition and Dietary Supplements · doi:10.2147/nds.s41517 · Cited by 6
β-Hydroxybutyrate improves β-cell mitochondrial function and survival
Sampson, M., Lathen, D. R., Dallon, B. W., Draney, C., Ray, J. D., Kener, K. B., Parker, B. A., Gibbs, J. L., Gropp, J. S., Tessem, J. S., et al. (2017) · Journal of Metabolic Health · doi:10.4102/jir.v2i1.25 · Cited by 6
Prevention of Neurologic Disease with Fasting
Macri, E., & Azhar, Y. (2022) · Seminars in Neurology · doi:10.1055/a-1957-8449 · Cited by 6
The Treatment of Parkinson’s Disease with Sodium Oxybate
Mamelak, M. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467216666221103121135 · Cited by 6
Kawakita, T., Uchino, M., Fukagawa, K., Yoshino, K., Shimazaki-Den, S., Toda, I., Tanaka, M., Arai, H., Sakatani, K., Hata, S., et al. (2016) · Scientific Reports · doi:10.1038/srep20855 · Cited by 6
Rojas, R., Griñán‐Ferré, C., Castellanos, A., Griego, E., Martínez, M., Navarro‐López, J. D., Jiménez‐Díaz, L., Rodrı́guez-Álvarez, J., Soto, D., Castillo, P. E., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102207 · Cited by 7
Murray, S. L., Vyas, G. R., Eberhardt, E., Roche, D. J. O., Adams, H. A., Harrington, V. M., Kearns, A., Glassman, M., Yuen, A., Chiappelli, J., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1710785 · Cited by 7
Wei, D., & Chen, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138328 · Cited by 5
Impact of ketogenic diet on cardiovascular disease
Zaghloul, M. S., Elizondo-Benedetto, S., & Zayed, M. A. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad152 · Cited by 5
Metadata
- Authors
- Tieu, K., Perier, C., Caspersen, C., Teismann, P., Wu, D.-C., Yan, S.-D., Naini, A., Vila, M., Jackson-Lewis, V., Ramasamy, R., & Przedborski, S.
- Affiliations
- Columbia University (US)
- Corresponding author
- Przedborski, Serge
- Venue
- Journal of Clinical Investigation
- Published
- 2003-09-15
- Volume
- 112
- Issue
- 6
- Pages
- 892-901
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC193668
- OpenAlex
- W4242174061
- Cited by
- 497
- References
- 43
- Citations by year
- 2026: 23 · 2025: 35 · 2024: 24 · 2023: 24 · 2022: 44 · 2021: 30 · 2020: 33 · 2019: 25 · 2018: 34 · 2017: 32 · 2016: 23 · 2015: 15 · 2014: 21 · 2013: 10 · 2012: 10
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- KU ScholarWorks (The University of Kansas) (submittedVersion, other-oa)
- Funders
- National Institutes of Health (5r29ns037345-05)
- National Institute of Neurological Disorders and Stroke (P50-NS38370, R01 NS 38586, R01 NS 42269, R29 NS37345, P01NS011766, R01NS042269, R01NS038586, P50NS038370, P01 NS11766-27A1)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- D-β-hydroxybutyrate, ketone bodies, Parkinson's disease, mitochondrial respiration, MPTP-induced neurotoxicity, dopaminergic neuron loss, complex II, neuroprotection, motor impairment, ATP production, blood-brain barrier
- MeSH terms
- Adenosine Triphosphate, Animals, Brain, Dopamine, Electron Transport, Humans, Hydrogen Peroxide, Hydroxybutyrate Dehydrogenase, Male, Mice, Inbred C57BL, Mitochondria, Motor Activity, NAD, NADH, NADPH Oxidoreductases, Neurons, Oxygen, Parkinson Disease, Tyrosine 3-Monooxygenase, Dopamine Agents, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Oxidants, Neuroprotective Agents, Cell Respiration, 3-Hydroxybutyric Acid, Electron Transport Complex I, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review